Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions

Neurology

Volumn 84, Issue 2, 2015, Pages 148-158

  Popescu, Bogdan F G ^a   Guo, Yong ^b   Jentoft, Mark E ^b   Parisi, Joseph E ^b   Lennon, Vanda A ^b   Pittock, Sean J ^b   Weinshenker, Brian G ^b   Wingerchuk, Dean M ^c   Giannini, Caterina ^b   Metz, Imke ^d   Brück, Wolfgang ^d   Shuster, Elizabeth A ^e   Carter, Jonathan ^c   Boyd, Clara D ^f   Clardy, Stacey Lynn ^b   Cohen, Bruce A ^g   Lucchinetti, Claudia F ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e MAYO CLINIC   (United States)

^f New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN G; MYELIN; AQP4 PROTEIN, HUMAN; AUTOANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN BIOPSY; CELL VACUOLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DEMYELINATING DISEASE; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; FOLLOW UP; GRANULOCYTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROMYELITIS OPTICA SPECTRUM DISORDER; PRIORITY JOURNAL; BIOPSY; BRAIN; DEMYELINATING AUTOIMMUNE DISEASES, CNS; IMMUNOLOGY; INFLAMMATION; MIDDLE AGED; MYELIN SHEATH; NEUROMYELITIS OPTICA; PATHOLOGY; SPINAL CORD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AQUAPORIN 4; ASTROCYTES; AUTOANTIBODIES; BIOPSY; BRAIN; CHILD; COHORT STUDIES; DEMYELINATING AUTOIMMUNE DISEASES, CNS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN SHEATH; NEUROMYELITIS OPTICA; SPINAL CORD; YOUNG ADULT;

EID: 84925956557     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.0000000000001126     Document Type: Article

References (40)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-2112.
2. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202:473-477.
3. Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007;130:1224-1234.
4. Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007;130: 1194-1205.
5. Apiwattanakul M, Popescu BF, Matiello M, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol 2010;68:757-761.
6. Magana SM, Matiello M, Pittock SJ, et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 2009;72:712-717.
7. Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 2005;65:1479-1482.
8. Takahashi T, Miyazawa I, Misu T, et al. Intractable hiccup and nausea in neuromyelitis optica with antiaquaporin- 4 antibody: A herald of acute exacerbations. J Neurol Neurosurg Psychiatry 2008;79:1075-1078.
9. Weinshenker BG, Wingerchuk DM. Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker. Curr Top Microbiol Immunol 2008;318:343-356.
10. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805-815.
11. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-1114.
12. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63:390-396.
13. Kim W, Kim SH, Lee SH, Li XF, Kim HJ. Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler 2011;17:1107-1112.
14. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006;63:964-968.
15. Viegas S, Weir A, Esiri M, et al. Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica. J Neurol Neurosurg Psychiatry 2009;80: 679-682.
16. Nakamura M, Misu T, Fujihara K, et al. Occurrence of acute large and edematous callosal lesions in neuromyelitis optica. Mult Scler 2009;15:695-700.
17. Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: A study on antibody titre. Brain 2007;130:1235-1243.
18. Bruck W, Popescu B, Lucchinetti CF, et al. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate. Ann Neurol 2012;72:385-394.
19. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002;125:1450-1461.
20. Misu T, Hoftberger R, Fujihara K, et al. Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica. Acta Neuropathol 2013;125:815-827.
21. Sato DK, Misu T, Rocha CF, et al. Aquaporin-4 antibodypositive myelitis initially biopsied for suspected spinal cor tumors: diagnostic considerations. Mult Scler 2014;20: 621-626.
22. Bruck W, Porada P, Poser S, et al. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 1995;38:788-796.
23. Hinson SR, Romero MF, Popescu BF, et al. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci USA 2012; 109,1245-1250.
24. Vass K, Lassmann H, Wekerle H, Wisniewski HM. The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol 1986;70:149-160.
25. Andreassi MG, Barale R, Iozzo P, Picano E. The association of micronucleus frequency with obesity, diabetes and cardiovascular disease. Mutagenesis 2011;26:77-83.
26. Lee DH, Metz I, Berthele A, et al. Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology. Neuropathol Appl Neurobiol 2010;36: 685-687.
27. Ringelstein M, Metz I, Ruprecht K, et al. Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. Mult Scler Epub 2013 Nov 5.
28. Matsuoka T, Suzuki SO, Suenaga T, Iwaki T, Kira J. Reappraisal of aquaporin-4 astrocytopathy in Asian neuromyelitis optica and multiple sclerosis patients. Brain Pathol 2011;21:516-532.
29. Graber JJ, Kister I, Geyer H, Khaund M, Herbert J. Neuromyelitis optica and concentric rings of Balo in the brainstem. Arch Neurol 2009;66:274-275.
30. Sobel RA, Moore GR. Demyelinating diseases. In: Love S, Louis DN, Ellison DW, eds. Greenfield's Neuropathology, 8th ed. Oxford: Oxford University Press; 2008:1513-1608.
31. Lampert P, O'Brien J, Garrett R. Hexachlorophene encephalopathy. Acta Neuropathol 1973;23:326-333.
32. Powell H, Swarner O, Gluck L, Lampert P. Hexachlorophene myelinopathy in premature infants. J Pediatr 1973; 82:976-981.
33. Popescu BF, Lucchinetti CF. Pathology of demyelinating diseases. Annu Rev Pathol 2012;7:185-217.
34. Norppa H, Falck GC. What do human micronuclei contain? Mutagenesis 2003;18:221-233.
35. Rosefort C, Fauth E, Zankl H. Micronuclei induced by aneugens and clastogens in mononucleate and binucleate cells using the cytokinesis block assay. Mutagenesis 2004; 19:277-284.
36. Rosin MP, Anwar WA, Ward AJ. Inflammation, chromosomal instability, and cancer: The schistosomiasis model. Cancer Res 1994;54:1929s-1933s.
37. Popescu BF, Parisi JE, Cabrera-Gomez JA, et al. Absence of cortical demyelination in neuromyelitis optica. Neurology 2010;75:2103-2109.
38. Saji E, Arakawa M, Yanagawa K, et al. Cognitive impairment and cortical degeneration in neuromyelitis optica. Ann Neurol 2013;73:65-76.
39. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489.
40. Papeix C, Vidal JS, deSeze J, et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 2007;13:256-259.